Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) Times Interest Earned (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Times Interest Earned for 6 consecutive years, with -$26.78 as the latest value for Q2 2020.

  • Quarterly Times Interest Earned fell 413.23% to -$26.78 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was -$138.92 through Jun 2025, changed N/A year-over-year, with the annual reading at -$22.71 for FY2024, 8.22% down from the prior year.
  • Times Interest Earned for Q2 2020 was -$26.78 at Outlook Therapeutics, down from -$9.72 in the prior quarter.
  • The five-year high for Times Interest Earned was $15.74 in Q3 2018, with the low at -$73.56 in Q2 2016.
  • Average Times Interest Earned over 5 years is -$15.45, with a median of -$7.36 recorded in 2018.
  • The sharpest move saw Times Interest Earned soared 1260.86% in 2018, then tumbled 483.75% in 2019.
  • Over 5 years, Times Interest Earned stood at -$36.38 in 2016, then surged by 87.82% to -$4.43 in 2017, then crashed by 106.61% to -$9.15 in 2018, then plummeted by 49.63% to -$13.69 in 2019, then plummeted by 95.55% to -$26.78 in 2020.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$26.78, -$9.72, and -$13.69 for Q2 2020, Q1 2020, and Q4 2019 respectively.